Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
Skip to main content

Dr Thomas Althaus

Dr Thomas Althaus

Podcast interview

Prescription of antibiotics at the point of care is very high in Southeast Asia. Simple tests can help health workers determine which patients actually need antibiotics, but we need to ensure that the benefits and advantages are clearly explained. In the long term, those tests could represent a sustainable alternative to the massive prescription of antibiotics in developing countries.

Thomas Althaus

Clinical Trial Coordinator

MAEMOD

I'm a DPhil candidate at the University of Oxford, based in Bangkok, and member of the Economics and Implementation Research Group (EIRG) headed by Professor Yoel Lubell.

My focus is on antimicrobial resistance (AMR), and more specifically, I aim to improve the prescription of antibiotics in low-resource settings. 

I am evaluating a biomarker named C-reactive protein (CRP), in order to help health workers identifying febrile patients who really need an antibiotic.

I have recently been coordinating a multi-country controlled-randomized clinical trial in Myanmar and Northern Thailand in febrile children and adults. We aim to demonstrate that CRP-testing could improve antibiotic prescription, not only by reducing prescriptions but by better identifying patients at risk of bacterial infections.

last, I am involved in determining the key pathogens among febrile patients attending primary care settings, in order to guide empirical treatment guidelines and evaluate  CRP performance in distinguishing bacterial from viral infections.

Key publications

Recent publications

More publications